Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) ≠ 2008
  • (-) = kidney transplantation

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(97 - 112 of 112)

Pages

Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine A in Renal Transplant Patients
Increased Metallothionein Expression Reflects Steroid Resistance in Renal Allograft Recipients
Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients
Difference in quality of life, fatigue and societal participation between living and deceased donor kidney transplant recipients
Cross-Validation of IFN- Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients
Mesenchymal stromal cells in renal ischemia/reperfusion injury
Mesenchymal stem cells derived from adipose tissue are not affected by renal disease
Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients
Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients
Mannan-Binding Lectin Mediates Renal Ischemia/Reperfusion Injury Independent of Complement Activation
Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis
KIR-Ligand Mismatches Are Associated With Reduced Long-Term Graft Survival in HLA-Compatible Kidney Transplantation
Donor Brain Death Predisposes Human Kidney Grafts to a Proinflammatory Reaction after Transplantation
Crosstalk between Complement and Toll-like Receptor Activation in Relation to Donor Brain Death and Renal Ischemia-Reperfusion Injury
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are Not Associated With Cyclosporine Pharmacokinetics Nor With Cyclosporine Clinical End Points After Renal Transplantation

Pages